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A B S T R A C T
Background: Imaging techniques used to measure hippocampal atrophy are key to understanding the clinical
progression of Alzheimer's disease (AD). Various semi-automated hippocampal segmentation techniques are
available and require human expert input to learn how to accurately segment new data. Our goal was to compare
1) the performance of our automated hippocampal segmentation technique relative to manual segmentations,
and 2) the performance of our automated technique when provided with a training set from two different raters.
We also explored the ability of hippocampal volumes obtained using manual and automated hippocampal
segmentations to predict conversion from MCI to AD.
Methods: We analyzed 161 1.5 T T1-weighted brain magnetic resonance images (MRI) from the ADCS
Donepezil/Vitamin E clinical study. All subjects carried a diagnosis of mild cognitive impairment (MCI). Three
different segmentation outputs (one produced by manual tracing and two produced by a semi-automated al-
gorithm trained with training sets developed by two raters) were compared using single measure intraclass
correlation statistics (smICC). The radial distance method was used to assess each segmentation technique's
ability to detect hippocampal atrophy in 3D. We then compared how well each segmentation method detected
baseline hippocampal differences between MCI subjects who remained stable (MCInc) and those who converted
to AD (MCIc) during the trial. Our statistical maps were corrected for multiple comparisons using permutation-
based statistics with a threshold of p < .01.
Results: Our smICC analyses showed significant agreement between the manual and automated hippocampal
segmentations from rater 1 [right smICC=0.78 (95%CI 0.72–0.84); left smICC=0.79 (95%CI 0.72–0.85)], the
manual segmentations from rater 1 versus the automated segmentations from rater 2 [right smICC=0.78
(95%CI 0.7–0.84); left smICC=0.78 (95%CI 0.71–0.84)], and the automated segmentations of rater 1 versus
rater 2 [right smICC=0.97 (95%CI 0.96–0.98); left smICC=0.97 (95%CI 0.96–0.98)]. All three segmentation
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methods detected significant CA1 and subicular atrophy in MCIc compared to MCInc at baseline (manual: right
pcorrected= 0.0112, left pcorrected= 0.0006; automated rater 1: right pcorrected= 0.0318, left pcorrected= 0.0302;
automated rater 2: right pcorrected= 0.0029, left pcorrected= 0.0166).
Conclusions: The hippocampal volumes obtained with a fast semi-automated segmentation method were highly
comparable to the ones obtained with the labor-intensive manual segmentation method. The AdaBoost auto-
mated hippocampal segmentation technique is highly reliable allowing the efficient analysis of large data sets.
1. Introduction
Alzheimer's disease (AD), the most common type of dementia, is a
slowly progressing disease affecting a rising number of individuals
every year. The structural integrity of AD patients' brains is often
compromised decades before they become symptomatic. There are
three stages to disease progression: the preclinical/ presymptomatic
stage, the prodromal stage of mild cognitive impairment (MCI), and the
dementia stage. MCI is the first stage where cognitive decline can be
objectively captured by neuropsychology testing using population-de-
rived normative data. While some MCI patients revert to normal cog-
nition, the majority progress to dementia at a rate of 10–15% per year
(Petersen, 2007; Petersen et al., 2001). Being able to identify MCI pa-
tients who will convert to AD will enable us to effectively halt or slow
down the progression of MCI to AD once disease-modifying treatments
are available.
Magnetic resonance (MR) imaging is an important tool used by
medical professionals in the diagnosis of patients with neurodegen-
erative disorders. It is also used abundantly in clinical research to study
disease progression or to examine correlations between atrophy and
other variables such as genetic profiles or performance on neu-
ropsychological tests. Hippocampal atrophy is a widely accepted ima-
ging biomarker for AD (Apostolova et al., 2006a, 2006b, 2010a, 2010b;
Chetelat et al., 2008; Csernansky et al., 2005; Frisoni et al., 2008; Jack
Jr. et al., 2000). Disease history studies and clinical trials are nowadays
enrolling hundreds of patients and rely on serial MR imaging to capture
brain atrophy rates. Manual hippocampal segmentation is a slow and
highly labor-intensive approach. Consequently, it is critical to develop
automated brain imaging techniques that can accurately extract hip-
pocampal structures from large datasets while using minimal human
operator input.
Several studies have proposed automated hippocampal segmenta-
tion techniques. One such study involved the patch-based method,
which uses expert traces as priors to segment anatomical structures. In
this method, each voxel is labeled individually and its surrounding
patch of voxels is compared to patches in the training set in order to
match anatomical regions of brain structures (Coupe et al., 2011).
Other studies use deformable shape (Yang and Duncan, 2004; Chupin
et al., 2007; Shen et al., 2002), appearance-based (Hu et al., 2011;
Duchesne et al., 2002), and atlas-based (Hammers et al., 2007; Collins
et al., 1994) models for hippocampal segmentation. More recently,
segmentation techniques are being developed that incorporate different
aspects from these three models (Morra et al., 2008a; Lotjonen et al.,
2010; van der Lijn et al., 2008).
Despite that multiple techniques for automated hippocampal seg-
mentation have been developed and embraced by many for analyzing
large data sets, there are ongoing concerns in the research community
regarding their accuracy given the fact that brain structures, especially
the subcortical regions, display significant anatomic complexity and
variation. Several groups are therefore working on approaches to
overcome these problems. One group has suggested using template sets
that are specific to the age of individuals in the cohort that is being
studied (Shen et al., 2012). Others have suggested that a common on-
line dataset of segmented hippocampi or other anatomical structures
should be developed and used as a validation tool (Jafari-Khouzani
et al., 2011; Heckemann et al., 2011). Some researchers state both
random and systematic errors in segmentation can be corrected (Wang
et al., 2011). Random errors, such as structural abnormalities, can be
corrected by combining segmentation data from multiple attempts.
Systematic errors caused by the misinterpretation of the manually
segmented images that serve as primers can be addressed by creating an
algorithm that detects them using model errors (Wang et al., 2011) or
by testing the segmentation performance of various primer sets as we
have done here.
The challenges brought about by the different factors that may
cause incorrect labeling of subcortical structures have led researchers to
come up with multiple features that are sensitive to anatomical varia-
tion (Morra et al., 2008a; Wang et al., 2011; Tangaro et al., 2014). To
label hippocampal tissues correctly, our automated technique takes into
account approximately 13,000 features. Among these features are
image intensity, gradients, curvatures, tissue classification maps of gray
and white matter as well as CSF, means and standard deviations, Haar
filters, and combinations of x, y, and z positions (Morra et al., 2008a).
The algorithm's performance has been validated in prior reports, and,
when labeling new data previously unseen by the algorithm, it has been
found to agree with human raters as well as human raters agree with
each other (Morra et al., 2008a). It has also been found to favorably
compare to the automated hippocampal segmentation method from the
Freesurfer packet (Morra et al., 2010).
In this study, we compare manual and automated hippocampal
segmentation methods in order to establish the reliability and re-
producibility of our machine learning based classification technique.
We trained our automated segmentation tool, called AdaBoost, with
training sets traced by two different experts and compared the volu-
metric and 3D shape outputs to each other and to the gold standard –
manual hippocampal segmentation of the same dataset. We hypothe-
sized that the three groups of segmentations would produce comparable
results. We also explored the ability of hippocampal volumes obtained
using manual and automated hippocampal segmentations to predict
conversion from MCI to AD.
2. Methods
2.1. Subjects
The Alzheimer's Disease Cooperative Study (ADCS) MCI Donepezil/
Vitamin E trial, conducted between March 1999 and January 2004,
enrolled 769 amnestic MCI subjects at 69 different sites in the United
States and Canada (Petersen et al., 2005). Qualifying study participants
were between the ages of 55 and 90 years, presented with impaired
memory performance on the Alzheimer's Disease Assessment Scale,
cognitive subscale (ADAS-Cog), and had a Clinical Dementia Rating
(CDR) score of 0.5. Additional eligibility criteria were Mini-Mental
State Examination (MMSE) score between 24 and 30 and Logical
Memory delayed-recall score within 1.5–2.0 standard deviations below
education-adjusted norms (Petersen et al., 2005). Participants were also
assessed using the ADCS Mild Cognitive Impairment Activities of Daily
Living Scale, the Global Deterioration Scale, and a neuropsychological
battery which included the New York University paragraph-recall test,
the Symbol Digit Modalities Test, the category-fluency test, a number-
cancellation test, the Boston Naming Test, the digits-backward test, the
clock-drawing test, and the Maze test (Petersen et al., 2005). Demo-
graphic details of the entire sample have been previously described
(Petersen et al., 2005). The study excluded subjects who met the
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National Institute of Neurological and Communicative Diseases and
Stroke and the AD and Related Disorders Association (NINCDS-ADRDA)
criteria for AD (McKhann et al., 1984). The same criteria were used by
the ADCS investigators' team in the course of the trial to define con-
version to possible or probable AD.
Of the 69 sites, 24 opted in the magnetic resonance images (MRI)
sub-study and obtained T1-weighted brain MRI images from consenting
clinical trial subjects. Subjects with contraindications to MRI (i.e. pa-
cemakers, claustrophobia, etc.) were excluded. The full MRI sample
included 194 subjects. Of these 194 subjects, 161 had both a baseline
scan of sufficient quality to allow for accurate and reliable hippocampal
tracing and sufficient data to be identified as MCI converters (MCIc) or
MCI subjects who remained stable (MCInc). All 161 subjects were in-
cluded in our manual segmentation analyses. 20 randomly selected
subjects were used as the training set for our automated technique (see
section Automated segmentation below). These subjects were excluded
from the automated segmentation analyses.
Of the 161 subjects two subjects discontinued prior to their first
follow-up. The manual segmentation sample size consisted of 62 MCIc
and 99 MCInc. The automated segmentation dataset included 52 MCIc
and 89 MCInc excluding the 10 MCIc and 10 MCInc subjects who were
used in the training set.
2.2. MRI acquisition, processing, and analyses
Of the 24 sites, 14 used General Electric, 9 used Siemens and one
used Philips scanners. T1-weighted scans with minimum full-time echo
and repetition time, 124 partitions, 25 degree flip and 1.6 mm slice
thickness were obtained. Details about the individual protocols have
been previously published (Jack Jr. et al., 2008). T2-weighted scans
were inspected for abnormalities such as strokes and major white
matter hyperintensities at the Mayo Clinic in Rochester, MN. The data
was checked for compliance with the imaging protocol and for quality
as explained elsewhere (Jack Jr. et al., 2008). Only scans that passed
quality control assessment at Mayo Clinic, Rochester were shared with
the University of California Los Angeles (UCLA) research team.
Using a 9-parameter linear transformation, each image was sepa-
rately registered to the ICBM53 standardized brain template (Collins
et al., 1994). All scans were intensity normalized (Shattuck et al.,
2001).
2.2.1. Manual segmentation
One expert rater [AEW, intrarater reliability= 0.98, interrater re-
liability relative to the senior author (LGA)=0.897 tested on a set of
12 hippocampi that were not part of this project] manually traced the
hippocampi of the 161 subjects with scans of sufficient quality to allow
manual tracing on gapless coronal slices following a detailed hippo-
campal tracing protocol (Bartzokis et al., 1998). The contours included
the hippocampus proper, the subiculum, and the dentate gyrus. AEW
remained blinded to the subjects' conversion status and demographic
information. Hippocampal volumes were extracted.
2.2.2. Automated segmentation
The automated method that we used in this study is described in
detail by Morra et al. (Morra et al., 2008b, 2008a, 2009, 2009a, 2009b,
2009c) 20 subjects (10 MCIc and 10 MCInc) were randomly selected as
the training dataset. The manual hippocampal traces of these 20 sub-
jects from rater 1 (AEW) and rater 2 (JS, interrater reliability= 0.96,
intrarater reliability relative to LGA=0.896; tested on a set of 12
hippocampi that were not part of this project] were used to develop the
semi-automated hippocampal segmentation approach. The tracers re-
mained blind to demographic and conversion information.
We trained AdaBoost - our automated machine-learning hippo-
campal segmentation algorithm (Morra et al., 2008a, 2009b) separately
with rater 1 and rater 2 hand-traced hippocampal training sets. From
each training set, AdaBoost developed a set of classification rules to
distinguish hippocampal from non-hippocampal tissue. These classifi-
cation rules were comprised of mathematical combinations of as many
of the ~13,000 different features as needed to achieve the most accu-
rate segmentation. Examples of such features include image intensity,
position, curvatures, gradients and tissue classification maps. The per-
formance of the segmentation models was tested in a testing dataset and
subjected to careful visual inspection by both raters and the senior
author (LGA) prior to segmentation of the full dataset. Hippocampal
volumes were extracted.
2.2.3. Radial distance mapping
The hippocampal segmentations produced with each of the three
methods (manual rater 1, automated rater 1 and automated rater 2)
were transformed into 3D parametric surface mesh models to normalize
the spatial frequency of the digitized surface points. The medial core - a
curve threading down the center of each hippocampus, was computed
and the radial distance from this medial core to every surface point of
each hippocampus was determined and mapped onto each point of the
hippocampal surface producing a distance map. Radial distance – a
measure of hippocampal thickness, was compared between MCIc and
MCInc for each segmentation dataset (manual rater 1, automated rater
1 and automated rater 2) (Apostolova et al., 2006a).
2.3. Statistical methods
We compared the demographic and conversion status character-
istics between the manual and automated cohorts using Student's t-test
for continuous and Chi-Squared test for categorical variables. We used
single measure intra-class correlation coefficient (smICC) to compare
the segmentation agreement between the three methods. Next, we
analyzed in 3D the ability of each method to detect hippocampal
atrophy between MCIc and MCInc. Our 3D significance maps were
adjusted for multiple comparisons using permutation-based statistics
with a threshold of p < .01 (Thompson et al., 2004).
Sensitivity, specificity and area under the curve (AUC) for conver-
sion to dementia using each of the segmentation methods were esti-
mated using logistic regression models. Sensitivity and specificity were
derived using a threshold set to equal the conversion rate in the sample.
3. Results
There were no statistical differences in age, gender, education,
apolipoprotein E (ApoE ε4) genotype distribution and MMSE between
the manual (N=161) and automated (N=141) cohorts (Table 1). We
found no significant differences in age, gender, education and ApoE ε4
genotype frequency between MCIc vs MCInc in the manual and auto-
mated cohorts (Table 2). As expected, MMSE was significantly lower in
MCIc vs MCInc, respectively, in both samples (mean ± SD: manual –
26.7 ± 1.9 vs. 28.0 ± 1.7, p < .001 and automated - 26.8 ± 1.8 vs.
28.0 ± 1.7, p < .001).
3.1. Manual versus automated segmentation
Single measure intra-class correlation coefficient (smICC) showed
Table 1
Demographic comparisons between samples.
Variable Manual dataset
N=161
Automated dataset
N=141
P-values
Age, years, mean (SD) 72.9 (6.8) 72.6 (6.9) p= .73
Gender, M:F 88:73 79:62 p= .45
Education, years, mean (SD) 15.1 (3.0) 15.06 (3.0) p= .98
ApoE ε4, noncarriers:carriers 82:79 74:67 p= .44
MCIc:MCInc 62:99 52:89 p= .43
MMSE, mean (SD) 27.5 (1.9) 27.5 (1.8) p= .96
S. Hurtz et al. NeuroImage: Clinical 21 (2019) 101574
3
significant agreement between the manual versus automated segmen-
tations of rater 1 [right smICC=0.78 (95% CI 0.72–0.84); left
smICC=0.79 (95% CI 0.72–0.85)]. Comparing manual rater 1 to au-
tomated rater 2 segmentations also yielded favorable results [right
smICC=0.78 (95% CI 0.7–0.84); left smICC=0.78 (95% CI
0.71–0.84)].
3.2. Rater 1 versus Rater 2 automated segmentation
Automated rater 1 versus rater 2 segmentations showed an ex-
tremely high level of agreement with each other [right smICC=0.97
(95% CI 0.96–0.98); left smICC=0.97 (95% CI 0.96–0.98)]. This in-
dicates that AdaBoost performs in a very stable and reliable fashion
independent of the inadvertent rater-introduced noise in segmentations
of the training dataset.
3.3. MCIc versus MCInc hippocampal atrophy comparisons
Significance maps showing diagnostic differences between MCIc
and MCInc were created using all three segmentation outputs (Fig. 1).
Statistical comparison of hippocampal radial distance between MCIc
and MCInc demonstrated the expected bilateral atrophy of the CA1 and
subiculum regardless of the segmentation method (manual rater 1: right
pcorrected= 0.0112, left pcorrected= 0.0006; automated rater 1: right
pcorrected= 0.0318, left pcorrected= 0.0302; automated rater 2: right
pcorrected= 0.0029, left pcorrected= 0.0166).
3.4. Prediction of conversion from MCI to dementia
Hippocampal volumes by themselves were not able to accurately
predict future conversion to dementia regardless of the segmentation
method (Table 3). The sensitivity of hippocampal volume to dis-
criminate MCIc from MCInc ranged from 51.9% to 61.5%, specificity
from 56.2% to 62.9% and the area under the curve from 0.602 to 0.677.
4. Discussion
Our analyses show that the AdaBoost automated hippocampal seg-
mentation technique accurately contours hippocampi and can be used
as a reliable substitute for manual delineation of the hippocampal
Table 2
Demographic comparisons between diagnostic groups within each sample.
Variable Manual dataset Automated dataset
MCInc
N=99
MCIc
N=62
p-value MCInc
N=89
MCIc
N=52
p-value
Age, years, mean (SD) 72.3 (6.7) 73.8 (6.8) 0.17 72.3 (6.9) 73.2 (6.9) 0.47
Education, years, mean (SD) 15.2 (2.8) 14.9 (3.3) 0.57 15.1 (2.7) 15.1 (3.5) 0.97
Gender, M:F 56:43 32:30 0.63 51:38 28:24 0.73
ApoE ε4, noncarriers:carriers 47:52 35:27 0.33 44:45 30:22 0.39
MMSE, mean (SD) 28.0 (1.7) 26.7 (1.9) p < .001 28.0 (1.7) 26.8 (1.8) p < .001
Fig. 1. Significance maps showing the atrophy pattern of MCIc compared to MCInc in the manual (left column), automated rater 1 (middle column) and automated
rater 2 (right column) datasets.
Table 3
Prediction of conversion to dementia.
Method Side Sensitivity, % Specificity, % AUC
Manual Left hippocampus 51.9 56.2 0.602
Right hippocampus 57.7 57.3 0.639
Automated rater 1 Left hippocampus 55.8 61.8 0.630
Right hippocampus 61.5 61.8 0.668
Automated rater 2 Left hippocampus 55.8 62.9 0.619
Right hippocampus 61.5 62.9 0.677
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structure, which currently remains the gold standard for hippocampal
segmentation. We were able to demonstrate that the volumes obtained
from the manual and the two automated segmentation approaches were
in significant agreement with each other. This suggests that AdaBoost
performs comparably to manual segmentation, as previously estab-
lished (Morra et al., 2008a, 2009b). We also demonstrate a highly
stable and robust AdaBoost performance when provided with training
sets traced by different raters, and performance stability in spite of
tracer-introduced segmentation noise. Both the manual and automated
segmentations proved sensitive to structural hippocampal differences
between MCI individuals who converted to AD, and those who re-
mained stable, as previously demonstrated in this trial population
(Apostolova et al., 2010b). We detected atrophy in the CA1 and sub-
iculum in MCIc compared to MCInc, a finding that was previously re-
ported by our group in several cohorts (Apostolova et al., 2006b,
2010b, 2012; Morra et al., 2009c; Chow et al., 2015). Our predictive
analyses however highlighted that hippocampal atrophy measured by
hippocampal volume by itself is a poor predictor of future conversion to
dementia. This is not an unexpected finding as hippocampal neurode-
generation is common among the elderly with MCI with and without
AD pathology (Wisse et al., 2018).
There are both strengths and limitations of the study that should be
recognized. Strengths include the selection of a large, well-defined,
prospectively collected, and well-characterized longitudinal MCI
sample, and the use of two sensitive, state-of-the-art hippocampal
analytic techniques (i.e. AdaBoost and radial distance mapping). One
weakness of the study relates to uneven sample sizes, with a relatively
small number of MCIc compared to MCInc included in the analysis.
Uneven sample sizes were the result of observed natural disease history
and conversion rates in the ADCS dataset, however a more balanced
number of subjects in each outcome group may have produced more
significant findings in terms of structural differences in the hippo-
campal formations. A limitation that is common among clinical trials is
that participants are frequently healthier than the general population.
Clinical trials have preset strict inclusion/exclusion criteria, which
when imposed at enrollment can lead to limited disease heterogeneity
in the sample, as may be the case for the current study. While epide-
miological MRI cohorts may include a more representative sample of
the population, and may therefore be better positioned to answer
questions about disease course, there remains tremendous value in
studying clinical trial samples such as the one studied here. In order to
test the generalization of our findings however, it would be informative
to repeat these analyses in other datasets. Furthermore, AdaBoost has
been used for the delineation of other subcortical structures such as the
basal ganglia (Apostolova et al., 2010c), highlighting its potential for
use in the delineation of various subcortical structures in AD and other
neurodegenerative diseases.
This work was completed before the Harmonized Protocol for
Hippocampal Segmentation (HarP) was developed (Bocchetta et al.,
2015). The protocol we used (Bartzokis et al., 1998) is thus not the
result of a strategically implemented Delphi procedure considering and
carefully weighing in various segmentation options employed by the
most common protocols as is the case with the HarP. A more detailed
protocol such as the HarP will further reduce the possibility of sub-
jective choice in defining regions which boundaries are not defined
unequivocally.
In summary, the AdaBoost automated hippocampal segmentation
technique provides reproducible results, which are comparable to
manually segmented hippocampi. Techniques such as this could be
easily employed to study normal disease progression and to detect
therapeutic effects on the neurodegenerative aspects of AD in clinical
trials. Creating reliable automated techniques to delineate subcortical
structures could significantly increase the momentum at which research
breakthroughs are made.
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